Cymbalta Approval History
FDA Approved: Yes (First approved August 3, 2004)
Brand name: Cymbalta
Generic name: duloxetine
Dosage form: Delayed-Release Capsules
Company: Eli Lilly and Company
Treatment for: Neuropathic Pain, Pain, Osteoarthritis, Generalized Anxiety Disorder, Depression, Major Depressive Disorder, Fibromyalgia, Diabetic Kidney Disease
Cymbalta is a selective serotonin and norepinephrine reuptake inhibitor (SSNRI) indicated for the treatment of major depressive disorder, neuropathic pain associated with diabetic peripheral neuropathy, generalized anxiety disorder, fibromyalgia and chronic musculoskeletal pain.
Development History and FDA Approval Process for Cymbalta
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.